The 10th edition of the Blockchain Africa Conference was successfully hosted by Bitcoin Events at the CSIR International Convention Centre, on November 20, 2024, in Tshwane, South Africa. The in-person event witnessed around 500 attendees, which included an impressive line-up of dignitaries along with aspiring and established participants from the blockchain and cryptocurrency spectrum in Africa and beyond.

The event venue, the CSIR International Convention Centre in Pretoria (Tshwane), is close to all major amenities, and is well-connected by all major routes in Gauteng. With over 10 years of experience, the Blockchain Africa Conference offers a robust platform for learning, networking and collaboration, attracting 9,500 attendees from 160 countries to date.

At the Blockchain Africa Conference, world-class speakers discussed the latest trends, disruptions, new technologies, and transformative concepts shaping global businesses and their impact on the African business sector. They shared their invaluable insights on cryptocurrency/digital asset regulation, and also spoke about the challenges and solutions of the digital assets community.

Leaders and innovators attending the Blockchain Africa Conference presented real-world case studies to provide participants with a contextual understanding of digital assets technology and the opportunities it presents for Africa. The conference offered well-structured content that considered the requirements of different stakeholders, industries and businesses. Most importantly, the event provided phenomenal networking and collaboration opportunities to drive economic growth and generate employment and development in Africa.

The exhibition floor had newbies and startups showcasing their latest innovations and technologies. The participants keenly attended the interactive workshops where they learned the intricacies of blockchain technology. The event played a formative role in empowering the attendees with the right knowledge and tools to help them navigate the digital assets landscape.

For more information, please visit https://ibn.fm/RrSEw.

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company pioneering transformative therapies for neurodegenerative diseases, recently hosted its Year-End Investor Webcast, providing stakeholders with a comprehensive overview of the company’s 2024 milestones and strategic initiatives for 2025. The full webcast is available here: https://youtu.be/NA3kCUZZIpI. During the webcast, Dr. Maria Maccecchini, Founder, President, and CEO of Annovis Bio, detailed significant progress in the company’s pivotal Phase 3 studies for Buntanetap, its lead drug candidate targeting neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases. These studies aim to demonstrate both symptomatic relief and disease-modifying effects, aligning with Annovis Bio’s mission to address the substantial unmet needs of patients and caregivers.

“2024 has been a year of significant progress for Annovis Bio, and we are excited about the opportunities ahead,” stated Dr. Maccecchini. “Our Phase 3 programs are designed to advance our understanding of neurodegeneration and bring us closer to delivering meaningful treatments that improve patients’ lives.”

The webcast also highlighted financial developments, including the recent securing of a $50 million At-The-Market (“ATM”) offering and ongoing strategic efforts to raise additional funds to support clinical trial development and long-term growth.

Webcast Highlights Include:

• Progress on pivotal Phase 3 Alzheimer’s and Parkinson’s clinical programs.
• Financial updates and future fundraising plans to support key initiatives.
• Insights into the company’s innovative approach targeting multiple neurotoxic proteins.
• Strategic plans for 2025 to drive regulatory and clinical milestones.

The event underscores Annovis Bio’s commitment to transparency and open communication with its investors as it continues to advance its mission to combat neurodegenerative diseases through innovative therapies.

About Annovis Bio Inc.

Headquartered in Malvern, Pennsylvania, Annovis Bio Inc. is dedicated to addressing neurodegeneration in diseases such as Alzheimer’s (“AD”) and Parkinson’s (“PD”). The company’s innovative approach targets multiple neurotoxic proteins, aiming to restore brain function and improve the quality of life for patients.

For more information, visit the company’s website at www.AnnovisBio.com, and social channels LinkedIn, X and YouTube.

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

• The FDA asked for additional Neurofilament Light (“NfL”) data from the company’s three Expanded Access Protocols to support earlier clinical trial findings.
• The company has already begun collecting and analyzing this data, with plans to complete the process in Q2 2025 and then submit a New Drug Application (“NDA”) for CNM-Au8 by mid-2025.
• A follow-up meeting with the FDA will be held early next year to discuss and finalize the statistical analysis plan for the EAP NfL biomarker analyses.
• The company is meanwhile preparing a confirmatory Phase 3 trial (“RESTORE-ALS”) to evaluate the survival benefit of CNM-Au8 with initial participant enrollment set to begin before NDA submission.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), has received additional written guidance and a roadmap from the U.S. Food and Drug Administration’s (“FDA”) Division of Neurology 1 regarding a potential accelerated approval pathway for lead drug candidate CNM-Au8 in ALS (https://ibn.fm/8VQGo).

CNM-Au8, an oral suspension of gold nanocrystals, works by improving cellular energy production and utilization, which is critical for maintaining neuronal health. The drug candidate has already been shown to improve central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the nicotinamide adenine dinucleotide (“NAD”) pathway while reducing oxidative stress. By targeting mitochondrial dysfunction, CNM-Au8 can provide neuroprotection and promote remyelination, potentially altering the course of neurodegenerative conditions.

The FDA guidance on a potential path to meet the regulatory standard for substantial evidence of effectiveness supporting accelerated approval came following an in-person November 1 Type C meeting with the DN1 where the company presented additional clinical trial data and analyses. The FDA recommended that Clene leverage additional Neurofilament Light (“NfL”) data from its three Expanded Access Programs (“EAPs”) to support earlier findings.

Clene intends to follow the FDA’s recommendation to provide data from the ongoing EAPs and believes that it can address the FDA’s requests. The company plans to complete the additional NfL biomarker collection and analyses to support an NDA submission for CNM-Au8 during the second quarter of 2025:

• NfL biomarker analyses: Present evidence of NfL reductions in participants enrolled in the three FDA-authorized compassionate use EAPs.
• Survival pharmacometric modeling: Analyze NfL and related disease-specific biomarkers to evaluate their association with clinical survival benefits and observed clinical changes in Phase 2 trial data.
• ALS-specific biomarker insights: Examine additional ALS-specific biomarkers to further support the pharmacodynamic activity of CNM-Au8 as a treatment for ALS.

Clene will have another meeting with the FDA in early 2025 to review and finalize its statistical analysis plan for the EAP NfL biomarker analyses. The FDA is expected to review whether NfL can serve as a likely surrogate endpoint for the effects of CNM-Au8 in ALS and whether the magnitude of change observed on NfL in patients treated with CNM-Au8 is likely to predict clinical benefit for ALS.

The FDA’s guidance was welcomed by Rob Etherington, President and CEO of Clene, who said the company was grateful for the regulatory body’s willingness to consider how available EAP data may support existing clinical study data to allow for the review of an accelerated regulatory pathway for CNM-Au8.

“Together with the survival and supportive biomarker data generated thus far, the drug’s benign safety profile, and the emerging EAP NfL data, we look forward to continued discussions with the Agency,” Etherington added. “Clene plans to include the additional data in an NDA submission under the accelerated approval pathway in mid-2025. We remain dedicated to the ALS community and honored to help critically ill patients and their families.”

Before filing the NDA, Clene intends to begin patient enrolment in a confirmatory Phase 3 RESTORE-ALS trial designed to investigate the effects of CNM-Au8 on improved survival (primary endpoint) and delayed time to ALS clinical worsening events (secondary efficacy endpoint).

Phase 2 clinical trial data as presented to the FDA revealed significant improvement in survival rates, functional status and combined assessment of function and survival. In addition, over 700 patient years of use of CNM-Au8 showed no significant safety concerns or safety trends. No serious adverse events have been identified as related to CNM-Au8 treatment by any investigator to date.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

• JPMorgan Chase shows significant interest in Brera Holdings, according to a recent SEC 6K filing, providing insight into institutional confidence and potential strategic alignments.
• The Chase investment signals confidence in Brera from a leading financial institution, enhancing its credibility among investors and partners.
• Brera’s recent investment in Juve Stabia, an Italian Serie B soccer club, aligns with the company’s multi-club ownership strategy.

Earlier this week JPMorgan Chase & Co. disclosed its 5.3% stake in Brera Holdings PLC via an SEC 6K filing through its investment management activities. Made in accordance with the Irish Companies Act, this announcement highlights Chase’s aggregate ownership of 351,400 Class B Ordinary Shares of Brera.

The SEC Form 6K is a regulatory report for foreign companies trading on U.S. exchanges. It ensures transparency by informing investors of material events, financial updates, and corporate changes. This specific filing reveals JPMorgan Chase’s significant interest in Brera Holdings, providing insight into institutional confidence and potential strategic alignments.

The disclosure showcases JPMorgan Chase’s role as a major institutional investor, reinforcing its influence in shaping the governance and strategic decisions of Brera Holdings. This stake may reflect JPMorgan’s belief in the long-term potential of Brera’s innovative multi-club sports ownership model and its global expansion strategy.

For Brera, the investment signals confidence from a leading financial institution, potentially enhancing its credibility among investors and partners. This could lead to improved access to capital, support for its ongoing acquisitions, and broader market visibility.

Brera Football Club has signed a term sheet to acquire a 51.72% shareholding in Juve Stabia, a Serie B soccer club in Italy, known as “The Second Team of Naples.” This acquisition aligns with Brera’s multi-club ownership strategy, strengthening its presence in the Naples region and enhancing competitiveness. The partnership aims to create new talent pathways and reinforce Brera’s dedication to integrating cultural and social impact with professional sports. Brera operates globally across Africa, Europe, and Asia, prioritizing innovation and community-focused approaches in sports management.

“After a thorough analysis and negotiations with leading Serie B clubs, Brera Holdings is extremely proud to invest in Juve Stabia, an important club with an ideal partner in President Andrea Langella,” said Brera executive chair and founder Daniel McClory. “Competing in the vibrant Naples metropolitan area, home to 3.5 million people with an unparalleled tradition of top-caliber football, makes Brera’s investment in Juve Stabia especially strategic.”

Brera’s dynamic approach reflects its aspirations to be a transformative player in sports ownership, with an innovative ownership model focused on multi-club football ownership, global branding strategies, community initiatives and community-driven social and cultural projects. With JPMorgan Chase’s support, the company is well-positioned to achieve its goals.

For more information,visit www.BreraHoldings.com.

• The Coretec Group is positioned at the forefront of the rapidly growing EV and energy storage markets with innovative silicon-based solutions.
• The Endurion program delivers advanced battery technology, addressing critical industry needs for energy density and cycle life.
• CHS technology provides industry-leading efficiency, scalability and versatility for clean technology applications.
• The company continues to demonstrate progress in intellectual property and partnerships to ensure sustained competitive advantages.
• Its experienced leadership team is driving strategic growth and market penetration.

The Coretec Group (OTCQB: CRTG) is a technology leader specializing in silicon-based solutions that advance energy storage, materials science and visualization technologies. Through cutting-edge developments like the Endurion program and CHS, the company is driving progress in electric vehicles (“EVs”), semiconductors and clean technology. Additionally, it is broadening its reach into 3D visualization with its CSpace platform, exemplifying its dedication to transformative advancements across diverse industries.

Headquartered in Ann Arbor, Michigan, The Coretec Group emphasizes sustainable growth through innovative technologies, addressing the evolving demands of global markets.

Technology

Endurion Program: Next-Generation Lithium-Ion Batteries

The Endurion program redefines lithium-ion battery performance by integrating silicon anodes to replace traditional graphite. This transformative technology delivers superior energy density, improved cycling stability, and longer runtime—crucial for applications like EVs and renewable energy systems.

Demonstrating stability over 500 cycles with widely used cathode materials such as LFP and NMC, the Endurion program is progressing toward commercialization, positioning The Coretec Group as a leader in next-generation energy storage.

CHS Technology: A Breakthrough in Silicon-Based Materials

The Coretec Group’s cyclohexasilane (“CHS”) technology offers unparalleled atom density, enabling advancements in high-growth industries such as semiconductors, energy storage and advanced lighting. This proprietary material enhances yield, scalability and overall performance, making it a cornerstone for industries transitioning to sustainable and efficient technologies.

CHS’s unique properties place it at the forefront of innovations powering the next generation of energy and electronics.

CSpace Technology: Innovative 3D Visualization

CSpace, The Coretec Group’s patented 3D volumetric display technology, provides glasses-free, high-resolution imagery for applications in medical imaging, automotive design and defense visualization. Capable of producing true 3D images viewable from all angles, CSpace is poised to transform how industries interact with complex datasets.

Although still in development, this groundbreaking platform highlights The Coretec Group’s commitment to pushing technological boundaries.

Market Opportunity

The Coretec Group operates within rapidly expanding industries, notably lithium-ion batteries and advanced silicon materials. The global lithium-ion battery market was valued at approximately $64.84 billion in 2023 and is projected to grow to $446.85 billion by 2032, exhibiting a compound annual growth rate of 23.33% during the forecast period, according to Fortune Business Insights.

This growth is driven by the increasing adoption of EVs and renewable energy storage solutions. By addressing critical challenges such as energy density and cycle life, the Endurion program positions the company to capture a significant share of this burgeoning market.

In parallel, the silicon precursor market is experiencing robust growth, fueled by demand from the solar, semiconductor and EV industries. The unique properties of CHS align with these trends, offering efficient and scalable solutions for manufacturers aiming to enhance productivity and reduce costs. With its dual focus on energy storage and advanced materials, The Coretec Group is well-positioned to capitalize on these high-growth opportunities.

Leadership Team

Michael Ussery, Chief Executive Officer, leverages decades of experience in diplomacy, investment and international development to lead with a vision for global progress and stability. A former U.S. Ambassador appointed by President Reagan, Ussery has driven transformative initiatives across Eastern Europe, Central Asia, Africa, and the Americas, co-founding the Romania Moldova Direct Fund and advising organizations such as the U.S. Department of State, Safi Apparel, and Corps Africa. His leadership encompasses business, non-profit and government sectors, with a distinguished career marked by strategic insight, board service and a commitment to revitalizing distressed economies and fostering sustainable development.

Jung Min Lee, Chief Operations Officer, oversees the company’s operations, ensuring the seamless integration of its advanced materials into high-impact applications. With a background in finance and project management, Lee plays a critical role in scaling the company’s innovations to meet market demands.

Antti Uusiheimala, Chief Financial Officer, is responsible for financial strategy and planning. With a proven track record in corporate finance and investment management, Uusiheimala supports The Coretec Group’s growth initiatives and fosters investor confidence through strategic fiscal oversight.

For more information, visit the company’s website at TheCoretecGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to CRTG are available in the company’s newsroom at https://ibn.fm/CRTG

• The GolfLync app can help users embrace year-round golf, whether they are traveling to warmer climates or looking for indoor simulators or winter-friendly courses.
• With over 155,000 downloads to date and an extensive network of users and venues, the platform can help users find the best location for winter golfing and pair them with like-minded players enthusiastic to brave the cold on the course.
• Winter golfing requires smart preparation and being equipped with the right gear against the elements, to ensure a memorable and enjoyable experience.

Winter may bring frost and snow to your local course, but for avid golfers, the season is simply an invitation to explore. Why pack away your clubs when you can discover golf-friendly destinations and connect with fellow enthusiasts? SportLync, Inc.’s GolfLync app, the ultimate social platform for golfers, makes it easier than ever to embrace year-round golf, whether you’re traveling to warmer climates or looking for winter-friendly courses near you.

Golfing in winter offers unique benefits that can elevate your love for the game. Escaping the chill to play on sun-drenched fairways lets you stay active and healthy, soak in some much-needed vitamin D, and, above all, beat any winter blues. Winter golf also presents an opportunity to play at world-class courses during their prime seasons in places like Florida, Arizona and other popular U.S. golfing destinations, or even international destinations like Spain and Portugal.

If you’d like to hone your golfing skills on a winter course, GolfLync has got you covered! With over 155,000 downloads across multiple platforms to date and an extensive network of users and venues, the platform can help you find the absolute best location for your winter golfing, and pair you with like-minded players who are as enthusiastic as you are to get out on the course, winter or any other season.

Just remember that winter golfing can require some thoughtful preparation to overcome the specific challenges of the season and location, from the colder temperatures to possible frost-covered greens in the mornings. This is why having the right gear can make the experience much more enjoyable, no matter the weather and how long you plan to spend on the course (https://ibn.fm/tkxSL). So, the next time you go out golfing in winter, you may want to consider the following items:

• Breathable, thermal base clothing layers to keep you warn and dry without limiting your range of motion,
• Golf gloves designed for winter temperatures for extra warmth and grip,
• Warm thermal beanie that locks heat in and absorbs any moisture from sweat,
• Waterproof golf shoes, ideally paired with thermal socks, to offer extra insulation and traction,
• Disposable or rechargeable hand warmers to keep your hands warm between swings, helping you maintain a good grip while preventing stiffness,
• Low-compression golf balls, designed to provide a better feel and distance in low temperatures,
• Golf cart cover to create a sheltered, insulated space that protects you from wind, rain and even snow,
• Waterproof golf bag cover, and/or a double canopy umbrella to protect your bags and clubs from the elements,
• Rubber golf tees instead of standard wooden or plastic tees, as they hold up better in the coldest conditions.

This winter don’t let the cold stop you from enjoying your favorite pastime. Turn the season into an adventure with GolfLync and create lasting memories on stunning courses. The app ensures you stay in the game, building connections and honing your skills throughout the year.

You can download the GolfLync app using the following text-anchored links:

• Android: GolfLync – Apps on Google Play
• iPhone: GolfLync

For more information about GolfLync, visit GolfLync, download the app, and connect with community on Facebook, X and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to SportLync are available in the company’s newsroom at https://ibn.fm/SPORT

For additional investor information, visit SportLync Investment.

• Adageis, with its virtual quality care manager and productivity suite, aims to improve healthcare delivery by helping providers streamline operations and increase revenue through value-based care metrics by implementing its patented ProActive Care Platform.
• Easily scalable and adaptable, the platform is designed to fit with the electronic medical record systems of any healthcare provider, regardless of size, locations or number of patients.
• A unique offering in the healthcare technology space, the ProActive Care Platform offers flexible integration, proactive efficiency and advanced predictive analysis capabilities.
• Adageis is targeting a share of the fast-growing healthcare AI market, which was valued at 19.27 billion in 2023.

Adageis, a forward-thinking healthcare technology company, is reshaping patient care through flexible AI-centric software solutions for healthcare systems and providers, including accountable care organizations (“ACOs”), clinically integrated networks (“CINs”) and independent physician associations (“IPAs”). With a unique value proposition in the healthcare technology space, the company is actively improving healthcare delivery and increasing value-based care revenue by streamlining operations via its ProActive Care Platform.

Integrating AI and machine learning, this easy-to-use platform works with existing electronic health records (“EHR”) systems and fits the needs of all current healthcare platforms, whether operated by providers owning a single clinic or a multispecialty healthcare system. Through a dedicated application program interface, the company can pair its platform with providers’ existing EHR systems. Their AI approach to advanced analytics and risk analysis empowers users to better identify high risk patients and quality care gaps, all while influencing everything from supply chain, to physical business location, to care delivery.

Importantly, this platform’s design eliminates the need for costly infrastructure upgrades or extensive staff training, reducing adoption barriers and enabling organizations to increase revenue and thrive in today’s complex value-based care environment. The platform is easily scalable, with various packages available to meet a wide range of user needs. The ProActive Care Platform also supports patient-centered care while optimizing reimbursements linked to quality metrics and value-based contracts.

Key features include:

• Value-Based Care Engine: One platform to enable an organization’s value-based care transformation, driving revenue from meeting value-based care metrics while providing high-quality patient care.
• Patented Risk Engine (“PRE”): AI-driven insights identify high-risk patients and care gaps, enabling providers to improve outcomes and manage costs effectively.
• Proactive Efficiency: Monitors patient health continuously, allowing for timely interventions beyond traditional office visits, improving care efficiency and reducing expenses.
• Flexible Integration: Compatible with leading EMR systems such as AthenaHealth, Cerner, eClinicalWorks, Allscripts, and Epic, ensuring smooth implementation without disrupting workflows or requiring extensive training.

The company’s efforts to revolutionize healthcare delivery via innovative software solutions are spearheaded by a leadership team with extensive experience in healthcare and technology. CEO Shane Speirs, MD, MBA, is a board-certified physician in family and geriatric medicine with extensive experience in healthcare leadership, data modeling and AI applications in healthcare delivery. CTO Bill Jentarra, MBA, has over 25 years of experience in architecting and implementing complex client relationship management and business intelligence solutions across various industries, including healthcare.

Headquartered in Arizona, Adageis is already driving meaningful change in the industry, as the global healthcare AI market is expanding rapidly amid growing demand for improved patient outcomes (https://ibn.fm/wDsy1). Strategic partnerships, including collaborations with HealthyU Clinics and integration as an AthenaHealth marketplace partner, further highlight the company’s relevance and adaptability in the evolving healthcare landscape, and its unique position to capitalize on these trends and capture a significant stake in the $19.27 billion healthcare AI market.

For more information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

• Brera Holdings, an Ireland-based international holding company with a global portfolio of men’s and women’s sports clubs, has committed to a strategic investment in SS Juve Stabia, a historic Italian Serie B football club
• The investment looks to reinforce Juve Stabia’s sporting competitiveness in Serie B and beyond, in a 52-48 strategic shareholding with the current majority owner, XX Settembre srl, and the club’s President, Andrea Langella
• This stamps Brera’s presence in Italy, having invested previously in the professional volleyball space
• It bolsters the company’s global portfolio while stamping its position as a key player in the football space in Europe and beyond

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach, announced on Dec. 9 that it had committed to a strategic investment in SS Juve Stabia, the second team of Naples and a historic Italian Serie B football club. The share purchase agreement’s completion and the transaction’s initial conclusion are set to close by Dec. 31, 2024, according to the binding term sheet signed by the different parties involved.

“After a thorough analysis and negotiations with leading Serie B clubs, Brera Holdings is extremely proud to invest in Juve Stabia, an important club with an ideal partner in President Andrea Langella,” noted Daniel McClory, Brera’s Executive Chairman, Founder and majority shareholder (https://ibn.fm/9dHbC).

The investment from Brera looks to reinforce Juve Stabia’s sporting competitiveness, not just in Serie B but beyond. Brera’s management believes that growing the club to where it is meant to be will require a collaborative effort from all the stakeholders, including the players. It brings together current majority owner XX Settembre srl and club President Andrea Langella in an approximate 52-48 strategic shareholding over three places through March 31, 2025.

“We welcome Brera’s strategic capital, and the Nasdaq listing of its MCO model are expected to bring Juve Stabia not just additional financial resources and support but expanded awareness of our brand and team, as well as human capital and player pathways between Brera’s teams on three continents,” noted Mr. Langella. “Juve Stabia shares the social impact mission of Brera and will extend their reach into the greater Naples area, starting with Castellammare di Stabia,” he added (https://ibn.fm/9dHbC).

Juve Stabia is key to Italy’s third-largest metropolitan area. In addition, it is strategically located near the famous historical sites of Pompeii and the Amalfi Coast. This aspect offers a unique blend of sporting and cultural significance in one of Italy’s most renowned regions. It also provides a unique revenue opportunity for Brera.

“Competing in the vibrant Naples metropolitan area, home to 3.5 million people with an unparalleled tradition of top-caliber football, makes Brera’s investment in Juve Stabia especially strategic,” noted Mr. McClory (https://ibn.fm/9dHbC).

As of October 2024, Brera owned full or majority stakes in three professional soccer clubs across Europe, Asia and Africa. In Italy, it also had a stake in the professional volleyball space. The addition of SS Juve Stabia strengthens its global portfolio while asserting the company as a key player in the European football space and globally. It also affirms the company’s commitment to growing this portfolio and creating shareholder value, having set out in January to proactively search to acquire an Italian Serie B football club as a means to expand into the country’s second division.

For Brera, this investment is both timely and strategic. It bolsters the company’s brand image, positioning and equity in the global sports space. For shareholders, this promises growth in the value of their shares while pointing to where the company is headed and the ambitious goals it has for the future.

For company information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

On Thursday, the incoming U.S. President Donald Trump revealed that David Sacks, a former Chief Operations Officer at PayPal Holdings Inc. (NASDAQ: PYPL), had been chosen to be the “White House AI and Crypto Czar.” This announcement marks the latest step that the President-elect has taken in his bid to overhaul American policy on various industries and sectors.

Using Truth Social, a social media platform owned by Trump, the President-elect explained that Sacks would be tasked to formulate a framework through which the cryptocurrency industry would get the regulatory clarity it had been yearning for. Such a framework, Trump added, would allow cryptos to thrive in America. Trump’s post didn’t confirm whether “Czar” would be part of Sacks’ job title.

David Sacks is part of a growing number of incoming officials that the new president expects to oversee policy changes relating to the cryptocurrency industry. Others who are expected to play a key role include the nominees who will chair the U.S. SEC (Securities and Exchange Commission) and the CFTC (Commodity Futures Trading Commission). An advisory council on crypto has also been created and will help to reshape policy on digital currencies.

It should be noted that many tech industry leaders backed Trump during his campaign to win the presidency. These backers hope regulation of the crypto and AI space is minimal so that innovation can thrive without being hampered by excessive regulation. Trump positioned himself as someone who would create a favorable environment for these new technologies to thrive, and tech industry giants like Elon Musk threw their weight (and massive cash injections) into his campaign.

Reacting to the announcement of Sacks’ appointment, Steve Jang, who has invested alongside Sacks in a number of AI and crypto ventures, commented that while Sacks would create some guardrails around AI and crypto, he would generally favor minimal regulation.

Jang further stated that he believed Sacks would be more inclined to regulate the ways in which AI is deployed rather than trying to enact rules governing the way AI models are developed and trained. California tried, unsuccessfully, to pass SB 4047, a bill that would have regulated the development of AI models. Vehement opposition from tech investors in Silicon Valley prompted the governor to veto that bill.

Bitcoin breached the $100,000 mark for the first time last week, just a day before Trump announced the choice of David Sacks. This bullish run is largely riding on the industry’s expectation that the new administration will be friendlier to the industry compared to the outgoing one.

The anticipated pro-AI and crypto policy changes could further speed up the rate at which artificial intelligence grows in America, and that, in turn, bodes well for companies like McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) that are focused on gold, silver and copper. These metals have a pivotal role in the burgeoning industry.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

• Torr Metals’ Filion Gold Project is strategically located in a prolific gold-endowed region of northern Ontario, offering 42 kilometers of untapped exploration potential along the Filion Fault
• Recent advancements include the completion of a comprehensive ~9 km² surface sampling program and initiation of ground magnetic and VLF-EM geophysical surveys, designed to identify and prioritize high-value drill targets
• With both Filion West and East permitted for drilling, Torr is poised to advance toward a pivotal phase in uncovering potential brand-new district-scale gold discoveries

Gold is often seen as a symbol of wealth and stability, serving as a hedge against economic uncertainty and a critical component in various industries. In recent years, the value and demand for gold have risen sharply, with recent projections noting that the precious gold could reach $3,000 (https://ibn.fm/NRDTZ). This growing demand has placed increasing importance on gold exploration to ensure a steady and sufficient supply.

Gold’s value lies not only in its monetary significance but also in its diverse industrial applications. Its unmatched properties—such as conductivity, malleability and resistance to corrosion—make it indispensable in electronics, medical devices and aerospace technologies. Additionally, gold plays a vital role in the creation of jewelry and as a reserve asset for central banks.

Experts point to several key factors leading to an increase in gold demand moving forward. Those factors include economic uncertainty, technological innovation, global wealth growth and central bank purchases. The combination of these factors has heightened the need for new gold discoveries to sustain supply and ensure long-term market stability. However, while the demand for gold continues to trend up, existing long-term operations face challenges with depleting reserves, declining ore grades, and disappearing new discoveries. To address this gap, early-stage greenfield exploration efforts, such as Torr’s Filion Project, are essential for identifying potential new deposits and replenishing the global supply chain.

Torr Metals Inc. (TSX.V: TMET) stands out in the junior gold exploration sector by pursuing a fresh frontier at its 100% owned Filion Gold Project (https://ibn.fm/nTdt6) in northern Ontario. While many junior explorers focus on revisiting projects with overworked occurrences, historical resources or existing open pits – areas where prior decades-long efforts have often fallen short – Torr is exploring a region with untapped high-grade gold and significant blue-sky potential that echoes the era of major grassroots discoveries such as the regional Hemlo gold camp. Strategically located adjacent to the Trans-Canada Highway 11, the district-scale 261 km² Filion Project also offers exceptional infrastructure within a secure and stable jurisdiction; embodying a bold, forward-looking approach to the next generation of gold exploration that is essential to meeting rising global demand.

Expanding on this innovative strategy, Torr Metals has completed a focused surface sampling program and initiated a ground geophysical survey at its Filion Gold Project, targeting key gold anomalies along the 42-kilometer-long, gold-rich Filion Fault system. These efforts in 2024 are testing the potential multi-kilometer extensions of six undrilled gold soil anomalies, originally identified in 2023, which are aligned with historical high-grade occurrences of up to 91.4 g/t Au over 0.3 meters. Concentrated within a 2-kilometer-wide corridor, these anomalies span strike lengths of up to 1.2 kilometers with grades reaching 1.32 g/t gold, yet they represent only 3% of the project’s total area. With the remaining 97% unexplored and no records of historical work, this district-scale project showcases immense untapped potential within a safe, mining-friendly jurisdiction renowned for hosting globally significant gold deposits.

“We are advancing toward a pivotal phase at the Filion Gold Project,” said Malcolm Dorsey, Torr Metals president and CEO. “The successful completion of a comprehensive soil sampling and prospecting grid in Filion West along with multiple high-priority discoveries highlights the project’s exceptional untapped potential, while adding significant value to our 2023 work.

“Equally exciting is the confirmation of shared structural controls with prospective geology in Filion East, indicating the potential for previously unknown gold endowment to extend over the 42 km strike-length of the Filion Fault system,” Dorsey continued. “With both Filion West and East permitted for drilling and the imminent commencement of a combined ground magnetic and VLF-EM geophysical survey, we are poised to refine our understanding of key anomalies. This integrated approach will help prioritize future drill targets, offering multiple unique opportunities for potentially significant new grassroots discoveries.”

To meet the growing gold demand, it is essential to explore new frontiers. The history of the Hemlo gold camp in Ontario, with its discovery in the 1980s, provides a clear example of the rewards that come from bold, greenfield exploration in underexplored areas. Despite carrying inherent risks, the potential for high-reward discoveries is significant, as seen in Hemlo’s transformation into one of Canada’s richest gold-producing areas.

Torr Metals’ Filion Gold Project exemplifies this risk-reward dynamic. Located in a comparably prospective but underexplored region of northern Ontario, the project covers 261 km², with 97% remaining unexplored. Despite limited historical exploration, efforts in just one year have already identified multiple new gold soil anomalies with strike lengths up to 1.2 kilometers and grades as high as 1.32 g/t gold in soil already indicating a significant footprint with the right scale for a potential large discovery. The untapped nature of the Filion Project mirrors the early days of Hemlo, where minimal prior exploration opened the door to a brand-new world-class gold deposit.

Situated with direct access to highways and surrounded by major mining companies, the Filion Project combines untapped gold potential with key infrastructure and a strong position in one of the world’s most prolific gold-producing belts, making for a rare and strategic opportunity that has the potential to provide that fresh new breakthrough discovery the gold industry desperately needs.

For more information, visit the company’s website at www.TorrMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to TMET are available in the company’s newsroom at https://ibn.fm/TMET